Skip to main content

Table 1 Baseline Demographics & Patient-Reported Outcomes

From: Online yoga in myeloproliferative neoplasm patients: results of a randomized pilot trial to inform future research

  Yoga Group (n = 27) Control Group (n = 21) Total (n = 48)  
  N (%) N (%) N (%) p
Age, years (M ± SD) 58.3 ± 9.3 55.0 ± 11.4 56.9 ± 10.3 0.28
Body Mass Index (M ± SD) 26.6 ± 5.4 26.2 ± 5.6 26.5 ± 5.4 0.81
Gender     0.71
 Male 2 (7.4) 1 (4.8) 3 (6.3)  
 Female 25 (92.6) 20 (95.2) 45 (93.8)  
Race     0.42
 Caucasian 25 (92.6) 20 (95.2) 45 (93.8)  
 Other 2 (7.4) 1 (4.8) 3 (6.3)  
Diagnosis     0.53
 Polycythemia Vera 10 (37.0) 5 (23.8) 15 (31.3)  
 Essential Thrombocythemia 9 (33.3) 10 (47.6) 19 (39.6)  
 Myelofibrosis 8 (29.6) 6 (28.6) 14 (29.2)  
Time Since Diagnosis     0.44
  < 1 year ago 3 (11.1) 4 (19.0) 7 (14.6)  
 1–3 years ago 4 (14.8) 4 (19.0) 8 (16.7)  
  > 3 years ago 20 (74.1) 13 (61.9) 33 (68.8)  
Presence of Enlarged Spleen     0.45
 Yes 8 (29.6) 9 (42.9) 17 (35.4)  
 No 17 (63.0) 12 (57.1) 29 (60.4)  
 Missing 2 (7.4) 0 (0.0) 2 (4.2)  
History of Anemia     0.23
 Yes 15 (55.6) 8 (38.1) 23 (47.9)  
 No 12 (44.4) 13 (61.9) 25 (52.1)  
Ruxolitinib/Other Janus Kinase-Inhibitor Treatment    0.65
 Yes 5 (18.5) 5 (23.8) 10 (20.8)  
 No 22 (81.5) 16 (76.2) 38 (79.2)  
Education     0.3
  < High School 0 (0.0) 0 (0.0) 0 (0.0)  
 High school diploma 2 (7.4) 0 (0.0) 2 (4.2)  
 Some college 1 (3.7) 2 (9.5) 3 (6.3)  
 Associates/2-year degree 3 (11.1) 0 (0.0 3 (6.3)  
 Bachelors degree 10 (37.0) 8 (38.1) 18 (37.5)  
 Graduate school or above 11 (40.7) 11 (52.4) 22 (45.8)  
Marital status     0.28
 Single 2 (7.4) 0 (0.0) 2 (4.2)  
 Partnered/in a relationship 1 (3.7) 2 (9.5) 3 (6.3)  
 Married 22 (81.5) 19 (90.5) 41 (85.4)  
 Separated 2 (7.4) 0 (0.0) 2 (4.2)  
 Divorced 0 (0.0) 0 (0.0) 0 (0.0)